agilon health, inc.
AGL
$1.20
-$0.005-0.42%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -240.17% | 299.74% | 54.09% | -274.14% | -- |
| Total Depreciation and Amortization | 23.90% | 17.66% | 37.15% | 52.59% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -9.41% | -177.20% | -85.56% | 43.12% | -- |
| Change in Net Operating Assets | 1,429.52% | 38.75% | 10.61% | 1,370.18% | -- |
| Cash from Operations | -87.45% | 33.05% | 126.84% | 40.83% | 11.73% |
| Capital Expenditure | 1.87% | -22.62% | 16.94% | 13.53% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 242.37% | -135.25% | 8,618.12% | 832.95% | -- |
| Cash from Investing | 286.77% | -144.89% | 1,174.58% | 522.00% | -9.06% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | 0.00% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -50.53% | -128.80% | 97.40% | -199.72% | 99.15% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,581.17% | -1,408.62% | 162.40% | 265.42% | 98.91% |